Plain-English translation of NCT07071714 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
Read our Colorectal Cancer research guide →Phase 2 — Testing in a bigger group (up to a few hundred people) to see if the treatment actually works and is still safe.
This trial is testing a new medication called SHR-8068, given as an injection, combined with standard cancer treatments to see if it works better and is safe for people with colorectal cancer. Researchers want to understand how well this combination works and what side effects patients might experience. The study will involve about 200 participants across multiple hospitals.
Colorectal cancer remains a serious disease, and doctors are always looking for new ways to improve treatment outcomes. This medication is being tested to see if adding it to existing cancer treatments could help patients live longer and with better quality of life.
You likely qualify if…
You likely don't qualify if…
You would receive SHR-8068 injections along with your standard cancer treatment. The study has two parts: Part A is for patients expected to live at least 2 years, while Part B is for those with a shorter expected lifespan (at least 12 weeks). You would attend regular clinic visits to receive the medication, have blood tests and imaging scans, and be monitored closely for side effects and how well the treatment is working.
AI-generated summary from trial data · Jun 3, 2026 · Not medical advice
China